These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26612199)

  • 1. Combined inhibition of complement and CD14 improved outcome in porcine polymicrobial sepsis.
    Skjeflo EW; Sagatun C; Dybwik K; Aam S; Urving SH; Nunn MA; Fure H; Lau C; Brekke OL; Huber-Lang M; Espevik T; Barratt-Due A; Nielsen EW; Mollnes TE
    Crit Care; 2015 Nov; 19():415. PubMed ID: 26612199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined inhibition of complement C5 and CD14 markedly attenuates inflammation, thrombogenicity, and hemodynamic changes in porcine sepsis.
    Barratt-Due A; Thorgersen EB; Egge K; Pischke S; Sokolov A; Hellerud BC; Lindstad JK; Pharo A; Bongoni AK; Rieben R; Nunn M; Scott H; Mollnes TE
    J Immunol; 2013 Jul; 191(2):819-27. PubMed ID: 23761634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ inflammation in porcine Escherichia coli sepsis is markedly attenuated by combined inhibition of C5 and CD14.
    Egge KH; Thorgersen EB; Pischke SE; Lindstad JK; Pharo A; Bongoni AK; Rieben R; Nunn MA; Barratt-Due A; Mollnes TE
    Immunobiology; 2015 Aug; 220(8):999-1005. PubMed ID: 25956456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double blockade of CD14 and complement C5 abolishes the cytokine storm and improves morbidity and survival in polymicrobial sepsis in mice.
    Huber-Lang M; Barratt-Due A; Pischke SE; Sandanger Ø; Nilsson PH; Nunn MA; Denk S; Gaus W; Espevik T; Mollnes TE
    J Immunol; 2014 Jun; 192(11):5324-31. PubMed ID: 24790148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Inhibition of C5 and CD14 Attenuates Systemic Inflammation in a Piglet Model of Meconium Aspiration Syndrome.
    Thomas AM; Schjalm C; Nilsson PH; Lindenskov PHH; Rørtveit R; Solberg R; Saugstad OD; Berglund MM; Strömberg P; Lau C; Espevik T; Jansen JH; Castellheim A; Mollnes TE; Barratt-Due A
    Neonatology; 2018; 113(4):322-330. PubMed ID: 29486477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined inhibition of C5 and CD14 efficiently attenuated the inflammatory response in a porcine model of meningococcal sepsis.
    Hellerud BC; Orrem HL; Dybwik K; Pischke SE; Baratt-Due A; Castellheim A; Fure H; Bergseth G; Christiansen D; Nunn MA; Espevik T; Lau C; Brandtzæg P; Nielsen EW; Mollnes TE
    J Intensive Care; 2017; 5():21. PubMed ID: 28261486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bride and groom in systemic inflammation--the bells ring for complement and Toll in cooperation.
    Barratt-Due A; Pischke SE; Brekke OL; Thorgersen EB; Nielsen EW; Espevik T; Huber-Lang M; Mollnes TE
    Immunobiology; 2012 Nov; 217(11):1047-56. PubMed ID: 22964230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-inflammatory effect of combined complement and CD14 inhibition is preserved during escalating bacterial load.
    Egge KH; Barratt-Due A; Nymo S; Lindstad JK; Pharo A; Lau C; Espevik T; Thorgersen EB; Mollnes TE
    Clin Exp Immunol; 2015 Sep; 181(3):457-67. PubMed ID: 25907631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined inhibition of complement and CD14 efficiently attenuated the inflammatory response induced by Staphylococcus aureus in a human whole blood model.
    Skjeflo EW; Christiansen D; Espevik T; Nielsen EW; Mollnes TE
    J Immunol; 2014 Mar; 192(6):2857-64. PubMed ID: 24516199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined blockade of complement C5 and TLR co-receptor CD14 synergistically inhibits pig-to-human corneal xenograft induced innate inflammatory responses.
    Islam R; Islam MM; Nilsson PH; Mohlin C; Hagen KT; Paschalis EI; Woods RL; Bhowmick SC; Dohlman CH; Espevik T; Chodosh J; Gonzalez-Andrades M; Mollnes TE
    Acta Biomater; 2021 Jun; 127():169-179. PubMed ID: 33785451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothesis: combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response.
    Mollnes TE; Christiansen D; Brekke OL; Espevik T
    Adv Exp Med Biol; 2008; 632():253-63. PubMed ID: 19025127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Inhibition of Complement and CD14 Attenuates Bacteria-Induced Inflammation in Human Whole Blood More Efficiently Than Antagonizing the Toll-like Receptor 4-MD2 Complex.
    Gustavsen A; Nymo S; Landsem A; Christiansen D; Ryan L; Husebye H; Lau C; Pischke SE; Lambris JD; Espevik T; Mollnes TE
    J Infect Dis; 2016 Jul; 214(1):140-50. PubMed ID: 26977050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of C5 or absence of C6 protects from sepsis mortality.
    Buras JA; Rice L; Orlow D; Pavlides S; Reenstra WR; Ceonzo K; Stahl GL
    Immunobiology; 2004; 209(8):629-35. PubMed ID: 15638131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of complement and CD14 in meconium-induced cytokine formation.
    Salvesen B; Fung M; Saugstad OD; Mollnes TE
    Pediatrics; 2008 Mar; 121(3):e496-505. PubMed ID: 18299306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases-C3 or C5 emerge together with CD14 as promising targets.
    Barratt-Due A; Pischke SE; Nilsson PH; Espevik T; Mollnes TE
    J Leukoc Biol; 2017 Jan; 101(1):193-204. PubMed ID: 27581539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous C5 and CD14 inhibition limits inflammation and organ dysfunction in pig polytrauma.
    Lupu L; Horst K; Greven J; Mert Ü; Ludviksen JAK; Pettersen K; Lau C; Li Y; Palmer A; Qin K; Zhang X; Mayer B; van Griensven M; Huber-Lang M; Hildebrand F; Mollnes TE
    Front Immunol; 2022; 13():952267. PubMed ID: 36059503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of complement and CD14 attenuates the Escherichia coli-induced inflammatory response in porcine whole blood.
    Thorgersen EB; Pharo A; Haverson K; Axelsen AK; Gaustad P; Kotwal GJ; Sfyroera G; Mollnes TE
    Infect Immun; 2009 Feb; 77(2):725-32. PubMed ID: 19047409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Endothelial Cell Activation by Escherichia coli and Staphylococcus aureus Is Mediated by TNF and IL-1β Secondarily to Activation of C5 and CD14 in Whole Blood.
    Nymo S; Gustavsen A; Nilsson PH; Lau C; Espevik T; Mollnes TE
    J Immunol; 2016 Mar; 196(5):2293-9. PubMed ID: 26800874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD14 and complement crosstalk and largely mediate the transcriptional response to Escherichia coli in human whole blood as revealed by DNA microarray.
    Lau C; Nygård S; Fure H; Olstad OK; Holden M; Lappegård KT; Brekke OL; Espevik T; Hovig E; Mollnes TE
    PLoS One; 2015; 10(2):e0117261. PubMed ID: 25706641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement factor 5 blockade reduces porcine myocardial infarction size and improves immediate cardiac function.
    Pischke SE; Gustavsen A; Orrem HL; Egge KH; Courivaud F; Fontenelle H; Despont A; Bongoni AK; Rieben R; Tønnessen TI; Nunn MA; Scott H; Skulstad H; Barratt-Due A; Mollnes TE
    Basic Res Cardiol; 2017 May; 112(3):20. PubMed ID: 28258298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.